FactorPad
Build a Better Process

Stock Risk Measures for Amicus Therapeutics Inc

A quantitative factor review, as of September 30, 2020.
  1. Company Info - Description, identity and sector data.
  2. Share Data - Stock earnings and key dates.
  3. Market Risk - Beta, size, liquidity and momentum measures.
  4. Financial Risk - Earnings and dividends.
by Paul Alan Davis, CFA
Updated: October 01, 2020
See how we arrive at an overall risk score of 59 for FOLD below.

/ factorpad.com / stocks / f33tcp.html


An ad-free and cookie-free webpage by FactorPad


FOLD Risk Report

Overview

Our quantitative data points are meant to provide a high-level understanding of factors in equity risk models for Amicus Therapeutics Inc. Portfolio managers use these models to forecast risk, optimize portfolios and review performance.

We show how FOLD stock compares to 2,000+ US-based stocks, and to peers in the Health Technology sector and Biotechnology industry.

Please do not consider this data as investment advice. Data is downloaded from sources we deem reliable, but errors may occur.

Company Info

Business Description

Company logo Amicus Therapeutics, Inc. operates as a biotechnology company. The firm focuses on discovering, developing and delivering medicines for people living with rare metabolic diseases. Its product portfolio includes first and only approved oral precision medicine for people living with Fabry disease who have amenable genetic variants, a novel, clinical-stage, treatment paradigm for Pompe disease and a rare disease gene therapy portfolio. The company was founded by John Francis Crowley on February 4, 2002 and is headquartered in Cranbury, NJ.

Identity

Sector and Industry

Share Data

Shares and Float

Earnings and Dividends

Market Risk Measures

Many of the following risk metrics are standardized and transformed into quantitative factors in institutional-level risk models.

Rankings below represent percentiles from 1 to 100, with 1 being the lowest rating of risk.

Systematic Risk

Stocks with higher beta exhibit higher sensitivity to the ups and downs in the market. (↑↑)

Company Size

Stocks with higher market capitalization often have lower risk. (↑↓)

Trading Liquidity

Higher average daily dollar volume over the past 30 days implies lower liquidity risk. (↑↓)

Price Momentum

Higher price momentum stocks, aka recent winners, equate to lower risk for many investors. (↑↓)

Financial Risk Measures

Style risk factors often include measures of profitability and payout levels.

Earnings Yield

Companies with higher earnings generally provide lower risk. (↑↓)

Dividend Yield

Companies with higher dividend yields, if sustaintable, are perceived to have lower risk. (↑↓)

/ factorpad.com / stocks / f33tcp.html


FOLD stock risk
AMICUS THERAPEUTICS INC stock beta
FOLD risk report
FOLD f33tcp
FOLD risk analysis
FOLD volatility
AMICUS THERAPEUTICS INC credit risk
FOLD liquidity risk
FOLD leverage
FOLD valuation
FOLD systematic risk
FOLD specific risk
AMICUS THERAPEUTICS INC volatility
FOLD analysis
FOLD financial ratio

This is a new resource, spread the word, tell a friend